Lombard Odier Asset Management (USA)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-46,410	Closed	-$1.33M	–	192
2018 Q4	$1.33M	Sell	46,410 -53,590	-54%	-$1.53M	0.1%	109
2018 Q3	$4.44M	Buy	+100,000	New	+$4.44M	0.33%	64